Brian Bloom
Director/Board Member at APPILI THERAPEUTICS INC.
Net worth: 5 M $ as of 31/03/2024
Profile
Brian Bloom is the founder and currently holds the position of Chairman & Chief Executive Officer at Bloom Burton & Co., which was founded in 2008.
He is also currently serving as a Director at Appili Therapeutics, Inc., Triumvira Immunologics, Inc., Qing Bile Therapeutics, Inc., Triumvira Immunologics USA, Inc., and Satellos Bioscience, Inc. In his former positions, Mr. Bloom served as Chairman at Grey Wolf Animal Health, Inc. from 2015 to 2018, Director at The Baycrest Centre Foundation from 2011 to 2018, and Director at BIOTECanada from 2011 to 2019.
He also held positions as a Principal at TSG Group, Inc., DWM Securities, Inc., and Molecular Securities, Inc., and as a Research Associate at SCO Financial Group LLC.
Mr. Bloom obtained his undergraduate degree from McMaster University in 1998.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SATELLOS BIOSCIENCE INC
6.22% | 12/02/2024 | 7,021,070 ( 6.22% ) | 3 M $ | 31/03/2024 |
Grey Wolf Animal Health Corp.
11.63% | 09/05/2023 | 3,607,836 ( 11.63% ) | 2 M $ | 31/03/2024 |
| 29/04/2024 | 14,358,611 ( 11.84% ) | 344 607 $ | 31/03/2024 |
Brian Bloom active positions
| Companies | Position | Start |
|---|---|---|
| APPILI THERAPEUTICS INC. | Director/Board Member | 01/02/2019 |
| SATELLOS BIOSCIENCE INC. | Director/Board Member | 01/04/2018 |
Bloom Burton & Co.
 Bloom Burton & Co. Investment Banks/BrokersFinance Bloom Burton & Co. is an independent, Canadian broker/dealer headquartered in Toronto, Ontario. It was founded by Brian Bloom and Jolyon Burton in 2008. The firm offers bespoke execution services for healthcare institutional investors. They are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness. | Chief Executive Officer | 01/01/2008 |
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Director/Board Member | 01/05/2020 |
| Qing Bile Therapeutics, Inc. | Director/Board Member | 01/05/2015 |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Director/Board Member | 01/05/2020 |
Former positions of Brian Bloom
| Companies | Position | End |
|---|---|---|
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Director/Board Member | 01/05/2019 |
| The Baycrest Centre Foundation | Director/Board Member | 01/06/2018 |
Grey Wolf Animal Health, Inc.
 Grey Wolf Animal Health, Inc. Agricultural Commodities/MillingProcess Industries Grey Wolf Animal Health, Inc. provides animal health products. The firm offers in-house development and the in-license of mature products. The company was founded by Ian Sandler in March 2015 and is headquartered in Toronto, Canada. | Chairman | 01/05/2018 |
| ░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Brian Bloom
| McMaster University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| APPILI THERAPEUTICS INC. | Health Technology |
| SATELLOS BIOSCIENCE INC. | Health Technology |
| Private companies | 12 |
|---|---|
TSG Group, Inc.
 TSG Group, Inc. Financial ConglomeratesFinance TSG Group, Inc. currently has no operations. It was previously engaged in the business of provididing software technology for distributed, embedded, network-based and mobile systems. The company was founded on August 21, 1998 and is headquartered in Lindon, UT. | Finance |
DWM Securities, Inc.
 DWM Securities, Inc. Investment Banks/BrokersFinance Dundee Securities Corp. is a broker/dealer located in Toronto with additional offices in Montreal and Calgary. The firm is a subsidiary of Dundee Wealth Management, Inc. (TSE: DW). Dundee Securities is a full service investment dealer engaged in wealth management and financial advisory services, retail brokerage, institutional sales and trading, equity research and investment banking. The firm operates a sell-side institutional sales and trading floor. Dundee Securities is a member of the Investment Dealers Association of Canada and the CIPF. | Finance |
SCO Financial Group LLC
 SCO Financial Group LLC Investment Banks/BrokersFinance SCO Financial Group LLC operates a full service merchant bank, which is engaged in providing services to life sciences companies. It also offers fund management, investment banking and corporate partnering and licensing services to healthcare companies. The company was founded in 1997 and is headquartered in New York, NY. | Finance |
Molecular Securities, Inc.
 Molecular Securities, Inc. Investment ManagersFinance Molecular Securities, Inc. provides investment banking services. The private company is based in New York, NY. | Finance |
| The Baycrest Centre Foundation | Miscellaneous |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Bloom Burton & Co.
Bloom Burton & Co. Investment Banks/BrokersFinance Bloom Burton & Co. is an independent, Canadian broker/dealer headquartered in Toronto, Ontario. It was founded by Brian Bloom and Jolyon Burton in 2008. The firm offers bespoke execution services for healthcare institutional investors. They are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness. | Finance |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Health Technology |
Satellos Bioscience, Inc. /Old/
 Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Satellos Bioscience, Inc. is a regenerative medicine company. The firm is dedicated to developing novel therapeutics that stimulates or restore muscle regeneration in severe disorders. The company focuses on the discovery that dysregulated muscle stem-cell polarity a process that balances replenishment of muscle stem cells and production of specialized tissue cells can lead to the inability of the body to properly repair and regenerate muscle throughout life. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which the firm has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. It applies its proprietary MyoReGenXTM discovery platform to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated. Satellos also maintains the rights to two clinical stage legacy assets as a result of the reverse takeover of iCo Therapeutics Inc.: iCo-008 for potential use in eotaxin-1 mediated indications and an oral Amphotericin B delivery system. The company was founded by Frank Gleeson and Michael Rudnicki in 2018 and is headquartered in Toronto, Canada. | Health Technology |
Grey Wolf Animal Health, Inc.
Grey Wolf Animal Health, Inc. Agricultural Commodities/MillingProcess Industries Grey Wolf Animal Health, Inc. provides animal health products. The firm offers in-house development and the in-license of mature products. The company was founded by Ian Sandler in March 2015 and is headquartered in Toronto, Canada. | Process Industries |
| Qing Bile Therapeutics, Inc. | |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Commercial Services |
- Stock Market
- Insiders
- Brian Bloom